Intralesional Steroids in the Treatment of Alopecia Areata

Last Updated:
05/05/2016
Status:
Recruiting
Country:
United States
Eligibility:
Age 18-75; patch type alopecia areata
Drug:
Intralesional Triamcinolone
Administration:
Injection
Sponsor: 
Columbia University

Intralesional steroids are the most commonly used treatment for alopecia areata, yet much remains unknown about the risks and benefits of different doses of intralesional steroids. The goal of this study is to answer some of those questions. 

This study is currently recruiting participants at the following research centers: 

New York Presbyterian Hospital
Columbia University
New York, New York
Phone: 212-305-6953
Email: gu2102@columbia.edu
Click here for more information.

University of Minnesota 
Minneapolis, Minnesota
Phone: 612-624-5721
Email: derm@umn.edu